GB9828420D0 - CCR5 antagonists useful as anti-hiv agents - Google Patents

CCR5 antagonists useful as anti-hiv agents

Info

Publication number
GB9828420D0
GB9828420D0 GBGB9828420.1A GB9828420A GB9828420D0 GB 9828420 D0 GB9828420 D0 GB 9828420D0 GB 9828420 A GB9828420 A GB 9828420A GB 9828420 D0 GB9828420 D0 GB 9828420D0
Authority
GB
United Kingdom
Prior art keywords
hiv agents
antagonists useful
ccr5 antagonists
ccr5
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9828420.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GBGB9828420.1A priority Critical patent/GB9828420D0/en
Publication of GB9828420D0 publication Critical patent/GB9828420D0/en
Priority to PE1999001190A priority patent/PE20001420A1/en
Priority to US09/451,826 priority patent/US7217714B1/en
Priority to ARP990106086A priority patent/AR024233A1/en
Priority to EP99309589A priority patent/EP1013276A1/en
Priority to NZ511796A priority patent/NZ511796A/en
Priority to TR2001/01867T priority patent/TR200101867T2/en
Priority to EP99956267A priority patent/EP1140920A1/en
Priority to TR2002/00938T priority patent/TR200200938T2/en
Priority to HU0104910A priority patent/HUP0104910A3/en
Priority to IDW00200101365A priority patent/ID29031A/en
Priority to APAP/P/2001/002187A priority patent/AP2001002187A0/en
Priority to EA200100588A priority patent/EA200100588A1/en
Priority to GEAP19995957A priority patent/GEP20043161B/en
Priority to PL99349091A priority patent/PL349091A1/en
Priority to OA1200100160A priority patent/OA11732A/en
Priority to EEP200100344A priority patent/EE200100344A/en
Priority to JP2000591036A priority patent/JP3522691B2/en
Priority to US09/452,578 priority patent/US6586430B1/en
Priority to CA002350573A priority patent/CA2350573C/en
Priority to YU40701A priority patent/YU40701A/en
Priority to SK876-2001A priority patent/SK8762001A3/en
Priority to IL14351099A priority patent/IL143510A0/en
Priority to CZ20012297A priority patent/CZ20012297A3/en
Priority to BR9916585-6A priority patent/BR9916585A/en
Priority to US09/452,634 priority patent/US7041667B1/en
Priority to PCT/IB1999/001913 priority patent/WO2000039125A1/en
Priority to AU12904/00A priority patent/AU769449B2/en
Priority to KR1020017008078A priority patent/KR20010099931A/en
Priority to CNB998149810A priority patent/CN1150192C/en
Priority to TW088121100A priority patent/TW577888B/en
Priority to CO99075874A priority patent/CO5300387A1/en
Priority to PA19998487201A priority patent/PA8487201A1/en
Priority to EG159299A priority patent/EG24400A/en
Priority to ARP990106427A priority patent/AR023345A1/en
Priority to PE1999001255A priority patent/PE20001371A1/en
Priority to CA002292984A priority patent/CA2292984C/en
Priority to GCP1999452 priority patent/GC0000117A/en
Priority to UY25869A priority patent/UY25869A1/en
Priority to TNTNSN99253A priority patent/TNSN99253A1/en
Priority to GT199900221A priority patent/GT199900221A/en
Priority to IDW00200101366A priority patent/ID28965A/en
Priority to GT199900219A priority patent/GT199900219A/en
Priority to TNTNSN99252A priority patent/TNSN99252A1/en
Priority to DZ990279A priority patent/DZ2979A1/en
Priority to MA25868A priority patent/MA26714A1/en
Priority to JP36357899A priority patent/JP3779111B2/en
Priority to DZ990278A priority patent/DZ2978A1/en
Priority to MA25869A priority patent/MA26715A1/en
Priority to DE69943352T priority patent/DE69943352D1/en
Priority to BRPI9917007A priority patent/BRPI9917007B8/en
Priority to KR10-2001-7008122A priority patent/KR100425612B1/en
Priority to CA002350073A priority patent/CA2350073C/en
Priority to DK99959624.0T priority patent/DK1140085T3/en
Priority to AU16751/00A priority patent/AU763644B2/en
Priority to AT99959624T priority patent/ATE505190T1/en
Priority to HU0104795A priority patent/HU228754B1/en
Priority to EP99959624A priority patent/EP1140085B1/en
Priority to GEAP19995958A priority patent/GEP20033131B/en
Priority to TR2001/01793T priority patent/TR200101793T2/en
Priority to IL14351299A priority patent/IL143512A0/en
Priority to SI9931056T priority patent/SI1140085T1/en
Priority to CZ20012298A priority patent/CZ300926B6/en
Priority to ES99959624T priority patent/ES2362711T3/en
Priority to CN99815033A priority patent/CN1331591A/en
Priority to APAP/P/2001/002186A priority patent/AP1697A/en
Priority to OA1200100164A priority patent/OA11735A/en
Priority to PL349495A priority patent/PL201875B1/en
Priority to SK875-2001A priority patent/SK287020B6/en
Priority to BR9905977-0A priority patent/BR9905977A/en
Priority to NZ511794A priority patent/NZ511794A/en
Priority to EA200100589A priority patent/EA004988B1/en
Priority to HN1999000221A priority patent/HN1999000221A/en
Priority to PCT/IB1999/002048 priority patent/WO2000038680A1/en
Priority to EEP200100345A priority patent/EE05170B1/en
Priority to PT99959624T priority patent/PT1140085E/en
Priority to UA2001064397A priority patent/UA72750C2/en
Priority to JP2000590634A priority patent/JP3602795B2/en
Priority to YU38801A priority patent/RS51701B/en
Priority to PA19998488101A priority patent/PA8488101A1/en
Priority to MEP-2008-837A priority patent/ME00513B/en
Priority to ARP990106792A priority patent/AR023363A1/en
Priority to IS5944A priority patent/IS5944A/en
Priority to IS5941A priority patent/IS5941A/en
Priority to ZA200104211A priority patent/ZA200104211B/en
Priority to ZA200104254A priority patent/ZA200104254B/en
Priority to IL143512A priority patent/IL143512A/en
Priority to CR9879A priority patent/CR9879A/en
Priority to CR6393A priority patent/CR6393A/en
Priority to CR6392A priority patent/CR6392A/en
Priority to HRP20010468AA priority patent/HRP20010468B1/en
Priority to NO20013149A priority patent/NO20013149L/en
Priority to CU20010145A priority patent/CU23344A3/en
Priority to HR20010478A priority patent/HRP20010478A2/en
Priority to NO20013183A priority patent/NO330677B1/en
Priority to BG105709A priority patent/BG105709A/en
Priority to BG105721A priority patent/BG65448B1/en
Priority to DZ010081A priority patent/DZ3326A1/en
Priority to HK02101507.2A priority patent/HK1039902A1/en
Priority to HK02101506.3A priority patent/HK1039942B/en
Priority to JP2003358714A priority patent/JP2004099618A/en
Priority to CY20111100484T priority patent/CY1111504T1/en
Priority to HRP20120132AA priority patent/HRP20120132B1/en
Ceased legal-status Critical Current

Links

GBGB9828420.1A 1998-12-23 1998-12-23 CCR5 antagonists useful as anti-hiv agents Ceased GB9828420D0 (en)

Priority Applications (103)

Application Number Priority Date Filing Date Title
GBGB9828420.1A GB9828420D0 (en) 1998-12-23 1998-12-23 CCR5 antagonists useful as anti-hiv agents
PE1999001190A PE20001420A1 (en) 1998-12-23 1999-11-29 CCR5 MODULATORS
US09/451,826 US7217714B1 (en) 1998-12-23 1999-11-30 CCR5 modulators
ARP990106086A AR024233A1 (en) 1998-12-23 1999-11-30 CCR5 MODULATING COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, ITS USE IN MEDICINE.
EP99309589A EP1013276A1 (en) 1998-12-23 1999-11-30 Aminoazacycloalkanes as CCR5 modulators
NZ511796A NZ511796A (en) 1998-12-23 1999-12-01 Piperidines as CCR5 modulators
TR2001/01867T TR200101867T2 (en) 1998-12-23 1999-12-01 Piperidines as CCR5 modulators
EP99956267A EP1140920A1 (en) 1998-12-23 1999-12-01 Piperidines as ccr5 modulators
TR2002/00938T TR200200938T2 (en) 1998-12-23 1999-12-01 Piperidines as CCR5 modulators
HU0104910A HUP0104910A3 (en) 1998-12-23 1999-12-01 Piperidines as ccr5 modulators and pharmaceutical compositions containing them
IDW00200101365A ID29031A (en) 1998-12-23 1999-12-01 PIPERIDIN AS CCR5 MODULATOR
APAP/P/2001/002187A AP2001002187A0 (en) 1998-12-23 1999-12-01 Piperidines as CCR5 modulators.
EA200100588A EA200100588A1 (en) 1998-12-23 1999-12-01 PIPERIDINES AS CCR5 MODULATORS
GEAP19995957A GEP20043161B (en) 1998-12-23 1999-12-01 Piperidines as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Modulators
PL99349091A PL349091A1 (en) 1998-12-23 1999-12-01 Piperidines as ccr5 modulators
OA1200100160A OA11732A (en) 1998-12-23 1999-12-01 Piperidines as CCR5 modulators.
EEP200100344A EE200100344A (en) 1998-12-23 1999-12-01 Piperidines as modulators of CCR5
JP2000591036A JP3522691B2 (en) 1998-12-23 1999-12-01 Piperidines as CCR5 modulators
US09/452,578 US6586430B1 (en) 1998-12-23 1999-12-01 CCR5 modulators
CA002350573A CA2350573C (en) 1998-12-23 1999-12-01 Piperidines as ccr5 modulators
YU40701A YU40701A (en) 1998-12-23 1999-12-01 Piperidines as ccr5 modulators
SK876-2001A SK8762001A3 (en) 1998-12-23 1999-12-01 Piperidines as CCR5 modulators
IL14351099A IL143510A0 (en) 1998-12-23 1999-12-01 Piperidines as ccr5 modulators
CZ20012297A CZ20012297A3 (en) 1998-12-23 1999-12-01 Piperidines functioning as CCR5 modulators
BR9916585-6A BR9916585A (en) 1998-12-23 1999-12-01 Ccr5 modulators
US09/452,634 US7041667B1 (en) 1998-12-23 1999-12-01 CCR5 modulators
PCT/IB1999/001913 WO2000039125A1 (en) 1998-12-23 1999-12-01 Piperidines as ccr5 modulators
AU12904/00A AU769449B2 (en) 1998-12-23 1999-12-01 Piperidines as CCR5 modulators
KR1020017008078A KR20010099931A (en) 1998-12-23 1999-12-01 Piperidines as ccr5 modulators
CNB998149810A CN1150192C (en) 1998-12-23 1999-12-01 Piperidines as CCR5 modulators
TW088121100A TW577888B (en) 1998-12-23 1999-12-02 CCR5 modulators
CO99075874A CO5300387A1 (en) 1998-12-23 1999-12-02 CCR5 MODULATORS TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV)
PA19998487201A PA8487201A1 (en) 1998-12-23 1999-12-10 CCR5 MODULATORS
EG159299A EG24400A (en) 1998-12-23 1999-12-14 CCR5 modulators
ARP990106427A AR023345A1 (en) 1998-12-23 1999-12-15 CCR5 MODULATING COMPOUNDS, COMPOSITIONS, USE, ASSESSMENT METHOD OF A MUTANT ASSUMPTION OF HIV RETROVIRUS, MUTANT VIRUS, DIAGNOSTIC AGENT AND PROCEDURE TO DISCOVER THE PRESENCE AND / OR CONFIRM THE ACTIVITY OF A CHEMICAL MODULATOR
PE1999001255A PE20001371A1 (en) 1998-12-23 1999-12-15 CCR5 MODULATORS
CA002292984A CA2292984C (en) 1998-12-23 1999-12-21 Ccr5 modulators
GCP1999452 GC0000117A (en) 1998-12-23 1999-12-21 Ccr5 modulators.
UY25869A UY25869A1 (en) 1998-12-23 1999-12-21 CCR5 MODULATORS, PHARMACEUTICAL FORMULATIONS, PROCEDURES AND THEIR USES.
TNTNSN99253A TNSN99253A1 (en) 1998-12-23 1999-12-22 CHEMICAL COMPOUNDS NOVEL MODULATORS OF CCR5, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
GT199900221A GT199900221A (en) 1998-12-23 1999-12-22 CCR5 MODULATORS
IDW00200101366A ID28965A (en) 1998-12-23 1999-12-22 AZABISIKLOALKANA AS CCR5 MODULATOR
GT199900219A GT199900219A (en) 1998-12-23 1999-12-22 CCR5 MODULATORS
TNTNSN99252A TNSN99252A1 (en) 1998-12-23 1999-12-22 NOVEL MODULATORS OF CHIMIOKINE CCR5 AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DZ990279A DZ2979A1 (en) 1998-12-23 1999-12-22 Novel chemokine modulator compounds ccr5, and pharmaceutical compositions containing them.
MA25868A MA26714A1 (en) 1998-12-23 1999-12-22 NOVEL CHIMIOKINE CCR5 MODULATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
JP36357899A JP3779111B2 (en) 1998-12-23 1999-12-22 CCR5 modulator
DZ990278A DZ2978A1 (en) 1998-12-23 1999-12-22 New chemical compounds modulating ccr5, and pharmaceutical compositions containing them.
MA25869A MA26715A1 (en) 1998-12-23 1999-12-22 CHEMICAL COMPOUNDS NOVEL MODULATORS OF CCR5, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DE69943352T DE69943352D1 (en) 1998-12-23 1999-12-23 AZABICYCLOALCANES AS CCR5 MODULATORS
BRPI9917007A BRPI9917007B8 (en) 1998-12-23 1999-12-23 azabicycloalkanes as ccr5 modulators, pharmaceutical composition containing them, as well as their use
KR10-2001-7008122A KR100425612B1 (en) 1998-12-23 1999-12-23 Azabicycloalkanes as ccr5 modulators
CA002350073A CA2350073C (en) 1998-12-23 1999-12-23 Ccr5 modulators
DK99959624.0T DK1140085T3 (en) 1998-12-23 1999-12-23 Azabicycloalkane as CCR5 modulators
AU16751/00A AU763644B2 (en) 1998-12-23 1999-12-23 Azabicycloalkanes as CCR5 modulators
AT99959624T ATE505190T1 (en) 1998-12-23 1999-12-23 AZABICYCLOALKANES AS CCR5 MODULATORS
HU0104795A HU228754B1 (en) 1998-12-23 1999-12-23 Azabicycloalkanes as ccr5 modulators, pharmaceutical compositions comprising thereof and their use
EP99959624A EP1140085B1 (en) 1998-12-23 1999-12-23 Azabicycloalkanes as ccr5 modulators
GEAP19995958A GEP20033131B (en) 1998-12-23 1999-12-23 Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
TR2001/01793T TR200101793T2 (en) 1998-12-23 1999-12-23 Azabicycloalkanes as CCR5 modulators
IL14351299A IL143512A0 (en) 1998-12-23 1999-12-23 Azabicycloalkanes as ccr5 modulators
SI9931056T SI1140085T1 (en) 1998-12-23 1999-12-23 Azabicycloalkanes as ccr5 modulators
CZ20012298A CZ300926B6 (en) 1998-12-23 1999-12-23 Azabicycloalkane functioning as CCR5 modulator and pharmaceutical composition containing thereof
ES99959624T ES2362711T3 (en) 1998-12-23 1999-12-23 AZABICICLOALCANS AS MODULATORS OF CCR5.
CN99815033A CN1331591A (en) 1998-12-23 1999-12-23 Piperidines as CCR5 modulators
APAP/P/2001/002186A AP1697A (en) 1998-12-23 1999-12-23 Azabicycloalkanes as CCR5 modulators.
OA1200100164A OA11735A (en) 1998-12-23 1999-12-23 Azabicycloalkanes as CCR5 modulators.
PL349495A PL201875B1 (en) 1998-12-23 1999-12-23 Azabicycloalkanes as ccr5 modulators
SK875-2001A SK287020B6 (en) 1998-12-23 1999-12-23 Azabicycloalkane, its use and pharmaceutical composition containing it
BR9905977-0A BR9905977A (en) 1998-12-23 1999-12-23 Ccr5 modulators
NZ511794A NZ511794A (en) 1998-12-23 1999-12-23 Azabicycloalkanes useful as CCR5 modulators
EA200100589A EA004988B1 (en) 1998-12-23 1999-12-23 Azabicycloalkanes as ccrs modulators
HN1999000221A HN1999000221A (en) 1998-12-23 1999-12-23 CCR5 MODULATORS
PCT/IB1999/002048 WO2000038680A1 (en) 1998-12-23 1999-12-23 Azabicycloalkanes as ccr5 modulators
EEP200100345A EE05170B1 (en) 1998-12-23 1999-12-23 Azabits clalangans as modulators of CCR5, pharmaceutical compositions and combinations thereof and their medical use
PT99959624T PT1140085E (en) 1998-12-23 1999-12-23 Azabicycloalkanes as ccr5 modulators
UA2001064397A UA72750C2 (en) 1998-12-23 1999-12-23 Azabicycloalcanes as ccr5 modulators and pharmaceutical composition
JP2000590634A JP3602795B2 (en) 1998-12-23 1999-12-23 Azabicycloalkanes as CCR5 modulators
YU38801A RS51701B (en) 1998-12-23 1999-12-23 Azabicycloalkanes as ccr5 modulators
PA19998488101A PA8488101A1 (en) 1998-12-23 1999-12-23 CCR5 MODULATORS
MEP-2008-837A ME00513B (en) 1998-12-23 1999-12-23 Azabicycloalkanes as ccr5 modulators
ARP990106792A AR023363A1 (en) 1998-12-23 1999-12-28 COMPOUNDS DERIVED FROM 3,3-BIARILPIPERIDINA AND 2,2-BIARILMORFOLINA, COMPOSITION AND USE OF THE SAME
IS5944A IS5944A (en) 1998-12-23 2001-05-15 Azabicycloalkanes which CCR5 sets
IS5941A IS5941A (en) 1998-12-23 2001-05-15 Piperidine set by CCR5
ZA200104211A ZA200104211B (en) 1998-12-23 2001-05-23 Azabicycloalkanes as CCR5 modulators.
ZA200104254A ZA200104254B (en) 1998-12-23 2001-05-24 Piperidines as CCR5 modulators.
IL143512A IL143512A (en) 1998-12-23 2001-05-31 Azabicycloalkanes, pharmaceutical compositions comprising same and use thereof for the manufacture of medicaments for the prevention or treatment of infection by immunodeficiency virus
CR9879A CR9879A (en) 1998-12-23 2001-06-14 CCR5 MODULATORS (APPLICATION DIVISIONAL N ° 6392)
CR6393A CR6393A (en) 1998-12-23 2001-06-14 CCR5 MODULATORS
CR6392A CR6392A (en) 1998-12-23 2001-06-14 CCR5 MODULATORS
HRP20010468AA HRP20010468B1 (en) 1998-12-23 2001-06-19 Azabicycloalkanes as ccr5 modulators
NO20013149A NO20013149L (en) 1998-12-23 2001-06-22 Piperidines as CCR5 modulators
CU20010145A CU23344A3 (en) 1998-12-23 2001-06-22 AZABICICLOALCANS AS MODULATORS OF CCR5
HR20010478A HRP20010478A2 (en) 1998-12-23 2001-06-25 Piperidines as ccr5 modulators
NO20013183A NO330677B1 (en) 1998-12-23 2001-06-25 Azabicycloalkanes having CCR5 modulated effect, pharmaceutical compositions containing them and their use for the preparation of the compositions
BG105709A BG105709A (en) 1998-12-23 2001-07-16 Piperidines as ccr5 modulatiors
BG105721A BG65448B1 (en) 1998-12-23 2001-07-20 Azabicycloalkanes, pharmaceutical composition containing them, and use thereof as ccr5 modulators
DZ010081A DZ3326A1 (en) 1998-12-23 2001-11-19 Novel chemokine modulator compounds ccr5, and pharmaceutical compositions containing them.
HK02101507.2A HK1039902A1 (en) 1998-12-23 2002-02-27 Azabicycloalkanes as ccr5 modulators
HK02101506.3A HK1039942B (en) 1998-12-23 2002-02-27 Piperidines as ccr5 modulators
JP2003358714A JP2004099618A (en) 1998-12-23 2003-10-20 Piperidine as ccr5 modulator
CY20111100484T CY1111504T1 (en) 1998-12-23 2011-05-17 AZADICYLCOCALCANIA AS REGULATORS OF CCR5
HRP20120132AA HRP20120132B1 (en) 1998-12-23 2012-02-09 Azabicycloalkanes as ccr5 modulators

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9828420.1A GB9828420D0 (en) 1998-12-23 1998-12-23 CCR5 antagonists useful as anti-hiv agents

Publications (1)

Publication Number Publication Date
GB9828420D0 true GB9828420D0 (en) 1999-02-17

Family

ID=10844869

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9828420.1A Ceased GB9828420D0 (en) 1998-12-23 1998-12-23 CCR5 antagonists useful as anti-hiv agents

Country Status (4)

Country Link
ES (1) ES2362711T3 (en)
GB (1) GB9828420D0 (en)
GT (2) GT199900219A (en)
ZA (2) ZA200104211B (en)

Also Published As

Publication number Publication date
GT199900219A (en) 2002-03-22
GT199900221A (en) 2001-06-14
ZA200104211B (en) 2002-01-14
ZA200104254B (en) 2002-11-01
ES2362711T3 (en) 2011-07-12

Similar Documents

Publication Publication Date Title
HK1077742A1 (en) Rapidly disintegrable solid preparation
IL140249A0 (en) Muscarinic antagonists
HU9800876D0 (en) Liquid antacid compositions
GB9702238D0 (en) Compositions
GB2334721B (en) Cleansing composition
GB2337093B (en) Table construction
ZA987370B (en) Cleansing compositions
ZA987367B (en) Cleansing compositions
PL346396A1 (en) Preparation agents
ZA987365B (en) Cleansing compositions
AU2656799A (en) Metal-thiols as imminomodulating agents
GB9927195D0 (en) Auto-adhesive composition
HK1043590A1 (en) Muscarinic antagonists
GB9826555D0 (en) Microemulsion compositions
GB9722013D0 (en) Cleansing compositions
GB2331703B (en) Disinfectant compositions
GB9929801D0 (en) Anti-cancer agents iii
HUP0004862A3 (en) Novel compounds useful as neuro-protective agents
GB9717948D0 (en) Cleansing compositions
GB9828420D0 (en) CCR5 antagonists useful as anti-hiv agents
DE69940886D1 (en) Hiv impfstoff
ZA987369B (en) Cleansing compositions
GB9703109D0 (en) Compositions
GB9705340D0 (en) Compositions
GB9710933D0 (en) Microemulsion compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)